Boston Scientific Corporation
$42.17
−0.26 · −0.61% today
Market open · updated 12:44:26 PM ET
- High
- $42.74 5:30 AM
- Low
- $42.51 4:05 AM
Against the S&P 500 Price change through Oct 28, 2026
BSX−55.50%
S&P 500+13.26%
BSX−57.98%
S&P 500+12.41%
BSX−14.32%
S&P 500+88.06%
BSX−1.87%
S&P 500+68.51%
Key numbers
- Previous close
- $42.43
- Open
- $41.81
- Day's range
- $41.68 – $43.04
- 52-week range
- $39.57 – $105.65
- Volume
- 14.2 million
- Average volume
- 19.3 million
- Market value
- $61.1 billion
- Price to earnings
- 17.1last 12 months
- Earnings per share
- $2.48last 12 months
- Beta
- 0.57moves less than the market
- Dividend
- None
- 50-day average
- $45.13
- 200-day average
- $57.03
Analyst price targets and the full financials are in the terminal.
Who Boston Scientific sells to and competes with From our value chain
Boston Scientific in the news
- HeadlineBoston Scientific Q3 Earnings Call HighlightsMarketBeat · October 29, 2026 at 2:04 AM ET
- HeadlineBoston Scientific: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · October 28, 2026 at 11:45 PM ET
- HeadlineStock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack ImpactThe Motley Fool · October 28, 2026 at 4:50 PM ET
- HeadlineBSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock DownZacks Investment Research · October 28, 2026 at 1:21 PM ET
- HeadlineBoston Scientific Corporation (BSX) Q3 2026 Earnings Call TranscriptSeeking Alpha · October 28, 2026 at 1:09 PM ET
- HeadlineCompared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key MetricsZacks Investment Research · October 28, 2026 at 10:31 AM ET
- HeadlineBoston Scientific (BSX) Q3 Earnings Match EstimatesZacks Investment Research · October 28, 2026 at 8:51 AM ET
- Pre-market reportPre-Market: Fed Decision Looms as Vertiv Jumps, Boston Scientific SlidesWiseView Research desk · October 28, 2026
Congress trades in BSX
2 purchases and 6 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $50,001 - $100,000 | Sep 9, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $50,001 - $100,000 | Sep 4, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $1,001 - $15,000 | Sep 3, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $15,001 - $50,000 | Aug 31, 2026 | Sep 28, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Aug 18, 2026 | Sep 11, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Aug 10, 2026 | Sep 7, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Boston Scientific
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 59,000
- Headquarters
- Marlborough, Massachusetts
- Website
- bostonscientific.com
- Listed
- May 19, 1992
More medical - devices stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.